IP Library Granted Patent US 9,301,827
Granted Patent B2
US 9,301,827 · App. 14/171,088 · Granted Apr 5, 2016

Embolic implant and method of use

Inventors: Brian M. Strauss (Irvine, CA); Jeffrey J. Valko (Irvine, CA); Jay A. Lenker (Laguna Beach, CA); Robert A. Pecor (Irvine, CA); Peter Barker (Irvine, CA); Maricruz Castaneda (Irvine, CA)
Assignee: Covidien LP
A61F2/01A61B17/12031A61B17/12036A61B17/12109A61B17/12172A61F2/91A61L31/022A61L31/10A61L31/146A61B2017/00526A61B2017/00539A61B2017/00544A61B2017/00557A61B2017/00867A61B2017/12054A61B2017/12063A61B2017/12068A61B2017/12077A61B2017/12081A61B2017/12086A61B2017/12095A61F2002/823A61F2220/0058A61F2230/0071A61F2230/0076A61L2400/04A61L2400/14A61L2400/16A61L2420/04A61L2430/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,301,827
App. No.
14/171,088
Granted
Apr 5, 2016
Kind
B2
Abstract

A parent artery occlusion (PAO) device which provides for immediate occlusion of a cerebral artery to isolate a defect. The PAO device includes a self-expanding wire-frame prolate structure which is partially covered with an ePTFE membrane.

Claims (58)

1. An embolic implant, said embolic implant characterized by a proximal end and a distal end, said embolic implant comprising:

a wire frame structure characterized by a proximal end and a distal end, said wire-frame structure comprising:

a pair of opposing zigzag segments including a plurality of V-shaped elements defining an open end, the V-shaped elements joined at the open end of the V-shaped elements via short longitudinally aligned struts to form a central portion of the wire-frame structure, said short struts being longitudinally displaced from each other, said V-shaped elements defining proximal or distal vertices pointing proximally or distally away from the center of the wire frame structure;

a first plurality of longitudinally oriented struts extending from the proximally pointing vertices of the V-shaped elements, said longitudinally oriented struts being joined together near the radial center of the wireframe structure at the proximal end of the embolic implant;

a second plurality of longitudinally oriented struts extending from the distally pointing vertices of the V-shaped elements, said longitudinally oriented struts being joined together near the radial center of the wireframe structure at the distal end of the embolic implant;

wherein the wireframe structure is formed of a self-expanding material;

a detachment joint fixed to the proximal end of the embolic implant; and

a blood impermeable membrane disposed over the proximal end of the embolic implant, said blood impermeable membrane extending over at least one of the zigzag segments.

2. The embolic implant of claim 1 wherein the wire-frame structure further comprises a pseudoelastic metal alloy.

3. The embolic implant of claim 1 wherein the membrane comprises ePTFE impregnated with an adhesive, said membrane being glued to the wire-frame structure.

4. The embolic implant of claim 1 wherein the membrane comprises two layers of ePTFE impregnated with an adhesive, said membrane being glued to the wire-frame structure.

5. The embolic implant of claim 1 wherein the wire frame structure has a fully expanded configuration with a diameter of about 5 mm, and a second fully compacted configuration with a diameter of less than about 1 mm.

6. The system of claim 1 wherein the wire frame structure has a fully expanded configuration with a diameter of about 5 mm, and a second fully compacted configuration with a diameter of less than about 0.6 mm.

7. A system for occlusion of an artery, said system comprising:

an embolic implant characterized by a proximal end and a distal end, said embolic implant comprising:

a wire frame structure characterized by a proximal end and a distal end, said wire-frame structure comprising:

a pair of opposing zigzag segments including a plurality of V-shaped elements defining an open end, the V-shaped elements joined at the open end of the V-shaped elements via short longitudinally aligned struts to form a central portion of the wire-frame structure, said short struts being longitudinally displaced from each other, said V-shaped elements defining proximal or distal vertices pointing proximally or distally away from the center of the wire frame structure;

a first plurality of longitudinally oriented struts extending from the proximally pointing vertices of the V-shaped elements, said longitudinally oriented struts being joined together near the radial center of the wireframe structure at the proximal end of the embolic implant;

a second plurality of longitudinally oriented struts extending from the distally pointing vertices of the V-shaped elements, said longitudinally oriented struts being joined together near the radial center of the wireframe structure at the distal end of the embolic implant;

wherein the wireframe structure is formed of a self-expanding material;

an electrolytic detachment joint fixed to the proximal end of the embolic implant; and

a blood impermeable membrane disposed over the proximal end of the embolic implant, said blood impermeable membrane extending over at least one of the zigzag segments;

a delivery catheter adapted for navigation through the patient's vasculature to the parent artery, said delivery catheter also adapted to house the embolic implant within the distal tip of the delivery catheter;

a deliver rod slidably disposed within the delivery catheter, said delivery rod having a distal end fixed to the embolic implant via the electrolytic detachment joint; and

a conductor for supplying power to the electrolytic detachment joint from a power supply.

8. The system of claim 7 wherein the wire-frame structure further comprises a pseudoelastic metal alloy.

9. The system of claim 7 wherein the membrane comprises ePTFE impregnated with an adhesive, said membrane being glued to the wire-frame structure.

10. The system of claim 7 wherein the membrane comprises two layers of ePTFE impregnated with an adhesive, said membrane being glued to the wire-frame structure.

11. The system of claim 7 wherein the wire frame structure has a fully expanded configuration with a diameter of about 5 mm, and a second fully compacted configuration with a diameter of less than about 1 mm.

12. The system of claim 7 wherein the wire frame structure has a fully expanded configuration with a diameter of about 5 mm, and a second fully compacted configuration with a diameter of less than about 0.6 mm.

13. An embolic implant, said embolic implant characterized by a proximal end and a distal end, said embolic implant comprising:

a wire frame structure characterized by a proximal end and a distal end, said wire-frame structure comprising:

a pair of opposing zigzag segments including a plurality of V-shaped elements defining an open end, the V-shaped elements joined at the open end of the V-shaped elements via short longitudinally aligned struts to form a central portion of the wire-frame structure, said short struts being longitudinally displaced from each other, said V-shaped elements defining proximal or distal vertices pointing proximally or distally away from the center of the wire frame structure;

a plurality of longitudinally oriented struts extending from the proximally pointing vertices of the V-shaped elements, said longitudinally oriented struts being joined together near the radial center of the wire-frame structure at the proximal end of the embolic implant;

wherein the wireframe structure is formed of a self-expanding material;

a detachment joint fixed to the proximal end of the embolic implant; and

a membrane disposed over the proximal end of the embolic implant, said membrane having a proximal facing surface, said membrane being impermeable to blood on the proximal facing surface such that blood is substantially prevented from flowing through the implant when deployed in the parent artery.

14. The embolic implant of claim 13 wherein the wire-frame structure further comprises a pseudoelastic metal alloy.

15. The embolic implant of claim 13 wherein the membrane comprises ePTFE impregnated with an adhesive, said membrane being glued to the wire-frame structure.

16. The embolic implant of claim 13 wherein the membrane comprises two layers of ePTFE impregnated with an adhesive, said membrane being glued to the wire-frame structure.

17. The embolic implant of claim 13 wherein the wire frame structure has a fully expanded configuration with a diameter of about 5 mm, and a second fully compacted configuration with a diameter of less than about 1 mm.

18. The system of claim 13 wherein the wire frame structure has a fully expanded configuration with a diameter of about 5 mm, and a second fully compacted configuration with a diameter of less than about 0.6 mm.

19. A system for occlusion of an artery, said system comprising:

an embolic implant characterized by a proximal end and a distal end, said embolic implant comprising:

a wire frame structure characterized by a proximal end and a distal end, said wire-frame structure comprising:

a pair of opposing zigzag segments including a plurality of V-shaped elements, wherein each V-shaped element defines an open end, said V-shaped elements joined at the open end of the V-shaped elements via short longitudinally aligned struts to form a central portion of the wire-frame structure, said short struts being longitudinally displaced from each other, said V-shaped elements defining proximal or distal vertices pointing proximally or distally, respectively, away from the center of the wire frame structure;

a plurality of longitudinally oriented struts extending from the proximally pointing vertices of the V-shaped elements, said longitudinally oriented struts being joined together near the radial center of the wire-frame structure at the proximal end of the embolic implant;

wherein the wireframe structure is formed of a self-expanding material;

an electrolytic detachment joint fixed to the proximal end of the embolic implant; and

a membrane disposed over the proximal end of the embolic implant, said membrane having a proximal facing surface, said membrane being impermeable to blood on the proximal facing surface such that blood is substantially prevented from flowing through the implant when deployed in the parent artery;

a delivery catheter adapted for navigation through the patient's vasculature to the parent artery, said delivery catheter also adapted to house the embolic implant within the distal tip of the delivery catheter;

a deliver rod slidably disposed within the delivery catheter, said delivery rod having a distal end fixed to the embolic implant via the electrolytic detachment joint; and

a conductor for supplying power to the electrolytic detachment joint from a power supply.

20. The system of claim 19 wherein the wire-frame structure further comprises a pseudoelastic metal alloy.

21. The system of claim 19 wherein the membrane comprises ePTFE impregnated with an adhesive, said membrane being glued to the wire-frame structure.

22. The system of claim 19 wherein the membrane comprises two layers of ePTFE impregnated with an adhesive, said membrane being glued to the wire-frame structure.

23. The system of claim 19 wherein the wire frame structure has a fully expanded configuration with a diameter of about 5 mm, and a second fully compacted configuration with a diameter of less than about 1 mm.

24. The system of claim 19 wherein the wire frame structure has a fully expanded configuration with a diameter of about 5 mm, and a second fully compacted configuration with a diameter of less than about 0.6 mm.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE STATE PREVIOUSLY RECORDED AT REEL: 035087 FRAME: 0729. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 17, 2015
From: REVERSE MEDICAL LLC
To: COVIDIEN LP
Reel/Frame 035219/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2015
From: REVERSE MEDICAL LLC
To: COVIDIEN LP
Reel/Frame 035087/0729 →
CHANGE OF NAME Recorded Mar 4, 2015
From: REVERSE MEDICAL CORPORATION
To: REVERSE MEDICAL LLC
Reel/Frame 035128/0204 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2014
From: STRAUSS, BRIAN M; VALKO, JEFFREY J.; LENKER, JAY A; PECOR, ROBERT A; BARKER, PETER; CASTANEDA, MARICRUZ
To: REVERSE MEDICAL CORPORATION
Reel/Frame 032952/0596 →
Continuity (3)
Continuation 13483962 · May 30, 2012
Provisional Application 61493108 · Jun 3, 2011
Related Publication 20140148843A1 · May 29, 2014